SOLSTICE Week 24 Subgroup Analysis: Impact of Baseline Viral Parameters and Cirrhosis Status on Virological and Biochemical Responses in Participants With Chronic Hepatitis Delta Virus Infection Treated With Tobevibart and Elebsiran

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
May 7-10, 2025
Amsterdam the Netherlands


SOLSTICE Week 24 Subgroup Analysis: Impact of Baseline Viral Parameters and Cirrhosis Status on Virological and Biochemical Responses in Participants With Chronic Hepatitis Delta Virus Infection Treated With Tobevibart and Elebsiran

	EASL 2025 May 7-10 Amsterdam